The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial.

For some of the indicators that did not reach statistical significance, we analyzed that they might be affected by 1) sample size limitations, especially the small number of cases in some subgroup analyses; 2) heterogeneity of responses to Rg1 due to inter-individual metabolic differences; and 3) the short follow-up period of the study, where changes in some biomarkers had not yet been adequately revealed.

also in 111,027 other papers